Vergoeding 2019-2023 voor ATC-subgroep N05AX : Overige antipsychotica
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| N05AX08 Risperidon (Risperdal ®) | 4.612.300 | 4.459.800 | 3.771.500 | 3.579.900 | 3.295.900 |
| N05AX12 Aripiprazol (Abilify maintena ®) | 11.191.100 | 11.701.500 | 11.690.900 | 14.001.500 | 16.439.700 |
| N05AX13 Paliperidon (Xeplion ®) | 11.772.500 | 12.632.300 | 12.704.300 | 13.380.500 | 13.577.300 |
| N05AX15 Cariprazine (Reagila ®) | 151.150 | 338.410 | 376.650 | 474.260 | 600.420 |
| N05AX16 Brexpiprazol (Rxulti ®) | 37.899 | 163.060 | 205.840 | 224.180 | 257.230 |
| Totaal | 27.764.949 | 29.295.070 | 28.749.190 | 31.660.340 | 34.170.550 |